Report Overview
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process. Naturally occurring peptides are strings of amino acids present in all living organisms. Peptide therapy is used to treat various diseases. The peptide acts as an anti-infective growth hormone and even as an ion channel ligand. Peptide therapy can perform the same function. Developments in the global biotech and pharmaceutical industries have proven that peptide therapy can stimulate essential hormones. As we age, our body's endopeptide production is disturbed. Peptide therapy safely and effectively reintroduces important peptides into the body. Peptide therapy can treat neurological problems, diabetes, cancer, heart problems and many other diseases. In addition, peptide therapy can also improve muscle endurance, pain relief, injury recovery and aid in weight loss. During treatment, the peptides are delivered directly into the blood. Peptide therapeutics are growing rapidly in the pharmaceutical and biotech industries. Peptide therapy has grown in popularity in the global nutrition industry in recent years. Moreover, the global healthcare industry has rapidly adopted peptide drug delivery options. Peptide therapy has positively impacted human health by improving stamina and immunity and reducing adverse side effects caused by long-term chronic diseases. Rising geriatric population is the major driving factor for the development of the peptide therapeutics market. Furthermore, technological advancements in the pharmaceutical industry are considered to drive the growth of the market over the forecast period 2023 to 2032. Various peptide conjugates help reduce inflammation, act as antioxidants and promote weight loss. Booming health and nutrition industry is driving the demand for peptide drugs.
The global Peptide Therapy market size was estimated at USD 43110 million in 2023 and is projected to reach USD 71605.94 million by 2032, exhibiting a CAGR of 5.80% during the forecast period.
North America Peptide Therapy market size was estimated at USD 12377.90 million in 2023, at a CAGR of 4.97% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Peptide Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Peptide Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Peptide Therapy market in any manner.
Global Peptide Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
Market Segmentation (by Type)
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration
Market Segmentation (by Application)
Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Peptide Therapy Market
Overview of the regional outlook of the Peptide Therapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Peptide Therapy
1.2 Key Market Segments
1.2.1 Peptide Therapy Segment by Type
1.2.2 Peptide Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Peptide Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Peptide Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Peptide Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Peptide Therapy Market Competitive Landscape
3.1 Global Peptide Therapy Sales by Manufacturers (2019-2025)
3.2 Global Peptide Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Peptide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Peptide Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Peptide Therapy Sales Sites, Area Served, Product Type
3.6 Peptide Therapy Market Competitive Situation and Trends
3.6.1 Peptide Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Peptide Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Peptide Therapy Industry Chain Analysis
4.1 Peptide Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Peptide Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Peptide Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Peptide Therapy Sales Market Share by Type (2019-2025)
6.3 Global Peptide Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Peptide Therapy Price by Type (2019-2025)
7 Peptide Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Peptide Therapy Market Sales by Application (2019-2025)
7.3 Global Peptide Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Peptide Therapy Sales Growth Rate by Application (2019-2025)
8 Peptide Therapy Market Consumption by Region
8.1 Global Peptide Therapy Sales by Region
8.1.1 Global Peptide Therapy Sales by Region
8.1.2 Global Peptide Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Peptide Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Peptide Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Peptide Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Peptide Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Peptide Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Peptide Therapy Market Production by Region
9.1 Global Production of Peptide Therapy by Region (2019-2025)
9.2 Global Peptide Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Peptide Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Peptide Therapy Production
9.4.1 North America Peptide Therapy Production Growth Rate (2019-2025)
9.4.2 North America Peptide Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Peptide Therapy Production
9.5.1 Europe Peptide Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Peptide Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Peptide Therapy Production (2019-2025)
9.6.1 Japan Peptide Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Peptide Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Peptide Therapy Production (2019-2025)
9.7.1 China Peptide Therapy Production Growth Rate (2019-2025)
9.7.2 China Peptide Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Eli Lilly
10.1.1 Eli Lilly Peptide Therapy Basic Information
10.1.2 Eli Lilly Peptide Therapy Product Overview
10.1.3 Eli Lilly Peptide Therapy Product Market Performance
10.1.4 Eli Lilly Business Overview
10.1.5 Eli Lilly Peptide Therapy SWOT Analysis
10.1.6 Eli Lilly Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Peptide Therapy Basic Information
10.2.2 AstraZeneca Peptide Therapy Product Overview
10.2.3 AstraZeneca Peptide Therapy Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca Peptide Therapy SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Merck
10.3.1 Merck Peptide Therapy Basic Information
10.3.2 Merck Peptide Therapy Product Overview
10.3.3 Merck Peptide Therapy Product Market Performance
10.3.4 Merck Peptide Therapy SWOT Analysis
10.3.5 Merck Business Overview
10.3.6 Merck Recent Developments
10.4 Ipsen
10.4.1 Ipsen Peptide Therapy Basic Information
10.4.2 Ipsen Peptide Therapy Product Overview
10.4.3 Ipsen Peptide Therapy Product Market Performance
10.4.4 Ipsen Business Overview
10.4.5 Ipsen Recent Developments
10.5 Novo Nordisk
10.5.1 Novo Nordisk Peptide Therapy Basic Information
10.5.2 Novo Nordisk Peptide Therapy Product Overview
10.5.3 Novo Nordisk Peptide Therapy Product Market Performance
10.5.4 Novo Nordisk Business Overview
10.5.5 Novo Nordisk Recent Developments
10.6 Teva Pharmaceutical Industries
10.6.1 Teva Pharmaceutical Industries Peptide Therapy Basic Information
10.6.2 Teva Pharmaceutical Industries Peptide Therapy Product Overview
10.6.3 Teva Pharmaceutical Industries Peptide Therapy Product Market Performance
10.6.4 Teva Pharmaceutical Industries Business Overview
10.6.5 Teva Pharmaceutical Industries Recent Developments
10.7 Abbott Laboratories
10.7.1 Abbott Laboratories Peptide Therapy Basic Information
10.7.2 Abbott Laboratories Peptide Therapy Product Overview
10.7.3 Abbott Laboratories Peptide Therapy Product Market Performance
10.7.4 Abbott Laboratories Business Overview
10.7.5 Abbott Laboratories Recent Developments
10.8 Sanofi
10.8.1 Sanofi Peptide Therapy Basic Information
10.8.2 Sanofi Peptide Therapy Product Overview
10.8.3 Sanofi Peptide Therapy Product Market Performance
10.8.4 Sanofi Business Overview
10.8.5 Sanofi Recent Developments
10.9 J and J
10.9.1 J and J Peptide Therapy Basic Information
10.9.2 J and J Peptide Therapy Product Overview
10.9.3 J and J Peptide Therapy Product Market Performance
10.9.4 J and J Business Overview
10.9.5 J and J Recent Developments
10.10 Novartis
10.10.1 Novartis Peptide Therapy Basic Information
10.10.2 Novartis Peptide Therapy Product Overview
10.10.3 Novartis Peptide Therapy Product Market Performance
10.10.4 Novartis Business Overview
10.10.5 Novartis Recent Developments
10.11 Takeda
10.11.1 Takeda Peptide Therapy Basic Information
10.11.2 Takeda Peptide Therapy Product Overview
10.11.3 Takeda Peptide Therapy Product Market Performance
10.11.4 Takeda Business Overview
10.11.5 Takeda Recent Developments
10.12 Ferring
10.12.1 Ferring Peptide Therapy Basic Information
10.12.2 Ferring Peptide Therapy Product Overview
10.12.3 Ferring Peptide Therapy Product Market Performance
10.12.4 Ferring Business Overview
10.12.5 Ferring Recent Developments
10.13 AbbVie
10.13.1 AbbVie Peptide Therapy Basic Information
10.13.2 AbbVie Peptide Therapy Product Overview
10.13.3 AbbVie Peptide Therapy Product Market Performance
10.13.4 AbbVie Business Overview
10.13.5 AbbVie Recent Developments
10.14 Heinis
10.14.1 Heinis Peptide Therapy Basic Information
10.14.2 Heinis Peptide Therapy Product Overview
10.14.3 Heinis Peptide Therapy Product Market Performance
10.14.4 Heinis Business Overview
10.14.5 Heinis Recent Developments
10.15 Hemmo
10.15.1 Hemmo Peptide Therapy Basic Information
10.15.2 Hemmo Peptide Therapy Product Overview
10.15.3 Hemmo Peptide Therapy Product Market Performance
10.15.4 Hemmo Business Overview
10.15.5 Hemmo Recent Developments
10.16 Emcure Pharmaceutical
10.16.1 Emcure Pharmaceutical Peptide Therapy Basic Information
10.16.2 Emcure Pharmaceutical Peptide Therapy Product Overview
10.16.3 Emcure Pharmaceutical Peptide Therapy Product Market Performance
10.16.4 Emcure Pharmaceutical Business Overview
10.16.5 Emcure Pharmaceutical Recent Developments
10.17 Cipla
10.17.1 Cipla Peptide Therapy Basic Information
10.17.2 Cipla Peptide Therapy Product Overview
10.17.3 Cipla Peptide Therapy Product Market Performance
10.17.4 Cipla Business Overview
10.17.5 Cipla Recent Developments
10.18 Gland Pharma
10.18.1 Gland Pharma Peptide Therapy Basic Information
10.18.2 Gland Pharma Peptide Therapy Product Overview
10.18.3 Gland Pharma Peptide Therapy Product Market Performance
10.18.4 Gland Pharma Business Overview
10.18.5 Gland Pharma Recent Developments
10.19 Troikaa Pharmaceuticals
10.19.1 Troikaa Pharmaceuticals Peptide Therapy Basic Information
10.19.2 Troikaa Pharmaceuticals Peptide Therapy Product Overview
10.19.3 Troikaa Pharmaceuticals Peptide Therapy Product Market Performance
10.19.4 Troikaa Pharmaceuticals Business Overview
10.19.5 Troikaa Pharmaceuticals Recent Developments
10.20 Biological E
10.20.1 Biological E Peptide Therapy Basic Information
10.20.2 Biological E Peptide Therapy Product Overview
10.20.3 Biological E Peptide Therapy Product Market Performance
10.20.4 Biological E Business Overview
10.20.5 Biological E Recent Developments
11 Peptide Therapy Market Forecast by Region
11.1 Global Peptide Therapy Market Size Forecast
11.2 Global Peptide Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Peptide Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Peptide Therapy Market Size Forecast by Region
11.2.4 South America Peptide Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Peptide Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Peptide Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Peptide Therapy by Type (2025-2032)
12.1.2 Global Peptide Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Peptide Therapy by Type (2025-2032)
12.2 Global Peptide Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Peptide Therapy Sales (K MT) Forecast by Application
12.2.2 Global Peptide Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Peptide Therapy Market Size Comparison by Region (M USD)
Table 5. Global Peptide Therapy Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Peptide Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Peptide Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Peptide Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapy as of 2022)
Table 10. Global Market Peptide Therapy Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Peptide Therapy Sales Sites and Area Served
Table 12. Manufacturers Peptide Therapy Product Type
Table 13. Global Peptide Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Peptide Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Peptide Therapy Market Challenges
Table 22. Global Peptide Therapy Sales by Type (K MT)
Table 23. Global Peptide Therapy Market Size by Type (M USD)
Table 24. Global Peptide Therapy Sales (K MT) by Type (2019-2025)
Table 25. Global Peptide Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Peptide Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Peptide Therapy Market Size Share by Type (2019-2025)
Table 28. Global Peptide Therapy Price (USD/MT) by Type (2019-2025)
Table 29. Global Peptide Therapy Sales (K MT) by Application
Table 30. Global Peptide Therapy Market Size by Application
Table 31. Global Peptide Therapy Sales by Application (2019-2025) & (K MT)
Table 32. Global Peptide Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Peptide Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Peptide Therapy Market Share by Application (2019-2025)
Table 35. Global Peptide Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Peptide Therapy Sales by Region (2019-2025) & (K MT)
Table 37. Global Peptide Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Peptide Therapy Sales by Country (2019-2025) & (K MT)
Table 39. Europe Peptide Therapy Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Peptide Therapy Sales by Region (2019-2025) & (K MT)
Table 41. South America Peptide Therapy Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Peptide Therapy Sales by Region (2019-2025) & (K MT)
Table 43. Global Peptide Therapy Production (K MT) by Region (2019-2025)
Table 44. Global Peptide Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Peptide Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Peptide Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Peptide Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Peptide Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Peptide Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Peptide Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Eli Lilly Peptide Therapy Basic Information
Table 52. Eli Lilly Peptide Therapy Product Overview
Table 53. Eli Lilly Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Eli Lilly Business Overview
Table 55. Eli Lilly Peptide Therapy SWOT Analysis
Table 56. Eli Lilly Recent Developments
Table 57. AstraZeneca Peptide Therapy Basic Information
Table 58. AstraZeneca Peptide Therapy Product Overview
Table 59. AstraZeneca Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Peptide Therapy SWOT Analysis
Table 62. AstraZeneca Recent Developments
Table 63. Merck Peptide Therapy Basic Information
Table 64. Merck Peptide Therapy Product Overview
Table 65. Merck Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Merck Peptide Therapy SWOT Analysis
Table 67. Merck Business Overview
Table 68. Merck Recent Developments
Table 69. Ipsen Peptide Therapy Basic Information
Table 70. Ipsen Peptide Therapy Product Overview
Table 71. Ipsen Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Ipsen Business Overview
Table 73. Ipsen Recent Developments
Table 74. Novo Nordisk Peptide Therapy Basic Information
Table 75. Novo Nordisk Peptide Therapy Product Overview
Table 76. Novo Nordisk Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Recent Developments
Table 79. Teva Pharmaceutical Industries Peptide Therapy Basic Information
Table 80. Teva Pharmaceutical Industries Peptide Therapy Product Overview
Table 81. Teva Pharmaceutical Industries Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Teva Pharmaceutical Industries Business Overview
Table 83. Teva Pharmaceutical Industries Recent Developments
Table 84. Abbott Laboratories Peptide Therapy Basic Information
Table 85. Abbott Laboratories Peptide Therapy Product Overview
Table 86. Abbott Laboratories Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Abbott Laboratories Business Overview
Table 88. Abbott Laboratories Recent Developments
Table 89. Sanofi Peptide Therapy Basic Information
Table 90. Sanofi Peptide Therapy Product Overview
Table 91. Sanofi Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Sanofi Business Overview
Table 93. Sanofi Recent Developments
Table 94. J and J Peptide Therapy Basic Information
Table 95. J and J Peptide Therapy Product Overview
Table 96. J and J Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. J and J Business Overview
Table 98. J and J Recent Developments
Table 99. Novartis Peptide Therapy Basic Information
Table 100. Novartis Peptide Therapy Product Overview
Table 101. Novartis Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Novartis Business Overview
Table 103. Novartis Recent Developments
Table 104. Takeda Peptide Therapy Basic Information
Table 105. Takeda Peptide Therapy Product Overview
Table 106. Takeda Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Takeda Business Overview
Table 108. Takeda Recent Developments
Table 109. Ferring Peptide Therapy Basic Information
Table 110. Ferring Peptide Therapy Product Overview
Table 111. Ferring Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Ferring Business Overview
Table 113. Ferring Recent Developments
Table 114. AbbVie Peptide Therapy Basic Information
Table 115. AbbVie Peptide Therapy Product Overview
Table 116. AbbVie Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. AbbVie Business Overview
Table 118. AbbVie Recent Developments
Table 119. Heinis Peptide Therapy Basic Information
Table 120. Heinis Peptide Therapy Product Overview
Table 121. Heinis Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. Heinis Business Overview
Table 123. Heinis Recent Developments
Table 124. Hemmo Peptide Therapy Basic Information
Table 125. Hemmo Peptide Therapy Product Overview
Table 126. Hemmo Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Hemmo Business Overview
Table 128. Hemmo Recent Developments
Table 129. Emcure Pharmaceutical Peptide Therapy Basic Information
Table 130. Emcure Pharmaceutical Peptide Therapy Product Overview
Table 131. Emcure Pharmaceutical Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. Emcure Pharmaceutical Business Overview
Table 133. Emcure Pharmaceutical Recent Developments
Table 134. Cipla Peptide Therapy Basic Information
Table 135. Cipla Peptide Therapy Product Overview
Table 136. Cipla Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Cipla Business Overview
Table 138. Cipla Recent Developments
Table 139. Gland Pharma Peptide Therapy Basic Information
Table 140. Gland Pharma Peptide Therapy Product Overview
Table 141. Gland Pharma Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Gland Pharma Business Overview
Table 143. Gland Pharma Recent Developments
Table 144. Troikaa Pharmaceuticals Peptide Therapy Basic Information
Table 145. Troikaa Pharmaceuticals Peptide Therapy Product Overview
Table 146. Troikaa Pharmaceuticals Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Troikaa Pharmaceuticals Business Overview
Table 148. Troikaa Pharmaceuticals Recent Developments
Table 149. Biological E Peptide Therapy Basic Information
Table 150. Biological E Peptide Therapy Product Overview
Table 151. Biological E Peptide Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Biological E Business Overview
Table 153. Biological E Recent Developments
Table 154. Global Peptide Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 155. Global Peptide Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 156. North America Peptide Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 157. North America Peptide Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 158. Europe Peptide Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 159. Europe Peptide Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 160. Asia Pacific Peptide Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 161. Asia Pacific Peptide Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 162. South America Peptide Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 163. South America Peptide Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 164. Middle East and Africa Peptide Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 165. Middle East and Africa Peptide Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 166. Global Peptide Therapy Sales Forecast by Type (2025-2032) & (K MT)
Table 167. Global Peptide Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 168. Global Peptide Therapy Price Forecast by Type (2025-2032) & (USD/MT)
Table 169. Global Peptide Therapy Sales (K MT) Forecast by Application (2025-2032)
Table 170. Global Peptide Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Peptide Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Peptide Therapy Market Size (M USD), 2019-2032
Figure 5. Global Peptide Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Peptide Therapy Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Peptide Therapy Market Size by Country (M USD)
Figure 11. Peptide Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Peptide Therapy Revenue Share by Manufacturers in 2023
Figure 13. Peptide Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Peptide Therapy Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Peptide Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Peptide Therapy Market Share by Type
Figure 18. Sales Market Share of Peptide Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Peptide Therapy by Type in 2023
Figure 20. Market Size Share of Peptide Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Peptide Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Peptide Therapy Market Share by Application
Figure 24. Global Peptide Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Peptide Therapy Sales Market Share by Application in 2023
Figure 26. Global Peptide Therapy Market Share by Application (2019-2025)
Figure 27. Global Peptide Therapy Market Share by Application in 2023
Figure 28. Global Peptide Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Peptide Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Peptide Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Peptide Therapy Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Peptide Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Peptide Therapy Sales Market Share by Country in 2023
Figure 37. Germany Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Peptide Therapy Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Peptide Therapy Sales Market Share by Region in 2023
Figure 44. China Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Peptide Therapy Sales and Growth Rate (K MT)
Figure 50. South America Peptide Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Peptide Therapy Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Peptide Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Peptide Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Peptide Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Peptide Therapy Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Peptide Therapy Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Peptide Therapy Production (K MT) Growth Rate (2019-2025)
Figure 65. China Peptide Therapy Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Peptide Therapy Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Peptide Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Peptide Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Peptide Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Peptide Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Peptide Therapy Market Share Forecast by Application (2025-2032)
